PMID- 19128833 OWN - NLM STAT- MEDLINE DCOM- 20090616 LR - 20090325 IS - 1872-9142 (Electronic) IS - 0161-5890 (Linking) VI - 46 IP - 7 DP - 2009 Apr TI - L-type Ca2+ channels in mast cells: activation by membrane depolarization and distinct roles in regulating mediator release from store-operated Ca2+ channels. PG - 1267-77 LID - 10.1016/j.molimm.2008.11.011 [doi] AB - Store-operated Ca(2+) channels (SOCs) are considered to be the principal route of Ca(2+) influx in non-excitable cells. We have previously shown that in mast cells IgE+antigen (Ag) induces a dihydropyridine (DHP)-sensitive Ca(2+) influx independently of Ca(2+) store depletion. Since the DHP receptor is the alpha subunit of L-type Ca(2+) channels (LTCCs), we examined the possible role of LTCCs in mast cell activation. Mast cells exhibited substantial expression of the alpha(1C) (Ca(V)1.2) subunit mRNA and protein on their cell surface. IgE+Ag-induced Ca(2+) influx was substantially reduced by the LTCC inhibitor nifedipine, and enhanced by the LTCC activator (S)-BayK8644, whereas these agents had minimal effects on thapsigargin (TG)-induced Ca(2+) influx. These LTCC-modulating agents regulated IgE+Ag-induced cell activation but not TG-induced cell activation. Inhibition of SOCs by 2-aminoethoxydiphenyl borate reduced both degranulation and production of cytokines, including interleukin-13 and tumor necrosis factor-alpha, whereas LTCC modulation reciprocally regulated degranulation and cytokine production. IgE+Ag, but not TG, induced substantial plasma membrane depolarization, which stimulated a DHP-sensitive Ca(2+) response. Moreover, IgE+Ag-, but not TG-induced mitochondrial Ca(2+) increase was regulated by LTCC modulators. Finally, gene silencing analyses using small interfering RNA revealed that the alpha(1C) (Ca(V)1.2) LTCC mediated the pharmacological effects of the LTCC-modulating agents. These results demonstrate that mast cells express LTCCs, which becomes activated by membrane depolarization to regulate cytosolic and mitochondrial Ca(2+), thereby controlling mast cell activation in a distinct manner from SOCs. FAU - Yoshimaru, Tetsuro AU - Yoshimaru T AD - Division of Molecular Cell Immunology and Allergology, Advanced Medical Research Center, Nihon University Graduate School of Medical Science, 30-1 Oyaguchikami-cho Itabashi-ku, Tokyo 173-8610, Japan. FAU - Suzuki, Yoshihiro AU - Suzuki Y FAU - Inoue, Toshio AU - Inoue T FAU - Ra, Chisei AU - Ra C LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090106 PL - England TA - Mol Immunol JT - Molecular immunology JID - 7905289 RN - 0 (Antigens) RN - 0 (Antigens, Surface) RN - 0 (Calcium Channels, L-Type) RN - 0 (L-type calcium channel alpha(1C)) RN - 37341-29-0 (Immunoglobulin E) RN - 67526-95-8 (Thapsigargin) SB - IM MH - Animals MH - Antigens/pharmacology MH - Antigens, Surface/metabolism/physiology MH - Calcium Channels, L-Type/genetics/metabolism/*physiology MH - Calcium Signaling/drug effects/*physiology MH - Cells, Cultured MH - Immunoglobulin E/pharmacology MH - Mast Cells/drug effects/*immunology/*metabolism/physiology MH - Membrane Potentials/drug effects/genetics/*physiology MH - Mice MH - Mice, Inbred C57BL MH - Rats MH - Thapsigargin/pharmacology EDAT- 2009/01/09 09:00 MHDA- 2009/06/17 09:00 CRDT- 2009/01/09 09:00 PHST- 2008/04/16 00:00 [received] PHST- 2008/11/20 00:00 [revised] PHST- 2008/11/21 00:00 [accepted] PHST- 2009/01/09 09:00 [entrez] PHST- 2009/01/09 09:00 [pubmed] PHST- 2009/06/17 09:00 [medline] AID - S0161-5890(08)00758-X [pii] AID - 10.1016/j.molimm.2008.11.011 [doi] PST - ppublish SO - Mol Immunol. 2009 Apr;46(7):1267-77. doi: 10.1016/j.molimm.2008.11.011. Epub 2009 Jan 6.